Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$0.66 - $38.7 $30,228 - $1.77 Million
45,800 Added 53.92%
130,744 $91,000
Q3 2022

Nov 04, 2022

BUY
$1.06 - $36.9 $58,085 - $2.02 Million
54,798 Added 181.78%
84,944 $99,000
Q2 2022

Aug 03, 2022

BUY
$4.35 - $5.76 $46,544 - $61,632
10,700 Added 55.02%
30,146 $139,000
Q1 2022

May 02, 2022

BUY
$3.92 - $6.25 $15,166 - $24,181
3,869 Added 24.84%
19,446 $106,000
Q4 2021

Feb 23, 2022

BUY
$5.52 - $8.42 $85,985 - $131,158
15,577 New
15,577 $89,000

About PolyPid Ltd.


  • Ticker PYPD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,551,200
  • Market Cap $64.5M
  • Description
  • PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...
More about PYPD
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.